Murray Arthur Kaplan
Bristol-Myers Squibb
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Murray Arthur Kaplan.
International Journal of Pharmaceutics | 2000
Rajesh B. Gandhi; Joseph Ballard Bogardus; David E. Bugay; Robert Kevin Perrone; Murray Arthur Kaplan
Three solid state forms of stavudine designated forms I, II and III have been identified and characterized. Forms I and II are anhydrous polymorphs whereas form III is hydrated and is pseudopolymorphic with forms I and II. Physico-chemical and thermodynamic properties of the three solid state forms have been characterized. Solid-state stability and potential for interconversion of the forms to aid in the selection of preferred form for development and commercialization has been studied. Conditions of recrystallization governing the formation of thermodynamically most stable polymorphic form I devoid of other forms was identified.
Tetrahedron | 2000
Stan V. D'Andrea; D P Bonner; Joanne J. Bronson; Junius M. Clark; Ken L. DenBleyker; Joan Fung-Tomc; Shelley E. Hoeft; Thomas W. Hudyma; John D. Matiskella; Raymond F. Miller; Peter F. Misco; Michael J. Pucci; Roman Z. Sterzycki; Yuan Tsai; Yasutsuga Ueda; John A. Wichtowski; Janak Singh; Thomas P. Kissick; Jeffery T. North; Annie Pullockaran; Michael Humora; Brenda T Boyhan; Truc Chi Vu; Alan Fritz; J. Heikes; Rita Fox; Jollie D. Godfrey; Robert Kevin Perrone; Murray Arthur Kaplan; David R. Kronenthal
Abstract Cephalosporin derivatives containing a unique combination of lipophilic C-7 sidechains and polar C-3 thiopyridinium groups were synthesized and found to exhibit potent anti-MRSA activity in vitro and in vivo. The optimum C-7 sidechains utilized were 2,5-dichlorophenylthioacetamido and 2,6-dichloropyrid-4-ylthioacetamido. The C-3 thiopyridinium rings were substituted at nitrogen with amino acid and pyruvic acid groups that were designed to confer aqueous solubility as required for IV formulation. This paper describes the characteristics of these novel cephalosporins and highlights synthetic methods developed to allow their practical, large-scale syntheses.
Archive | 1993
Jerzy Golik; Dolatrai M. Vyas; John J Wright; Henry Wong; John F. Kadow; John K. Thottathil; Wen-Sen Li; Murray Arthur Kaplan; Robert Kevin Perrone; Mark D. Wittman
Archive | 1994
Jerzy Golik; John F. Kadow; Murray Arthur Kaplan; Wen-Sen Li; Robert Kevin Perrone; John K. Thottathil; Dolatrai M. Vyas; Mark D. Wittman; Henry Wong; John J Wright
Archive | 1978
Murray Arthur Kaplan; Alphonse P. Granatek
Archive | 1995
Robert Kevin Perrone; Scott R. Stenberg; Murray Arthur Kaplan; Akram Saab; Shreeram Agharkar
Archive | 1988
Murray Arthur Kaplan; Thomas W. Hudyma; Robert A. Lipper; Kun M. Shih; Susan D. Boettger
Archive | 1980
Murray Arthur Kaplan; Alphonse P. Granatek
Archive | 1974
Murray Arthur Kaplan; Alphonse P. Granatek
Archive | 1994
Murray Arthur Kaplan; Lawan Phusanti; Robert Kevin Perrone; Scott R. Stenberg; Shreeram Agharkar; Joseph Ballard Bogardus